메뉴 건너뛰기




Volumn 68, Issue 9, 2013, Pages 2099-2105

Nystatin nanosizing enhances in vitro and in vivo antifungal activity against Candida albicans

Author keywords

Drug delivery; Nanosuspensions; Oral candidiasis

Indexed keywords

AGAR; CORTISONE ACETATE; L SELECTIN; NYSTATIN; SODIUM CHLORIDE;

EID: 84882637134     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt137     Document Type: Article
Times cited : (37)

References (43)
  • 3
    • 5644233700 scopus 로고    scopus 로고
    • Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection
    • de Repentigny L, Lewandowski D, Jolicoeur P. Immunopathogenesis of oropharyngeal candidiasis in human immunodeficiency virus infection. Clin Microbiol Rev 2004; 17: 729-59.
    • (2004) Clin Microbiol Rev , vol.17 , pp. 729-759
    • de Repentigny, L.1    Lewandowski, D.2    Jolicoeur, P.3
  • 4
    • 40349100417 scopus 로고    scopus 로고
    • Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge
    • Spellberg B. Novel insights into disseminated candidiasis: pathogenesis research and clinical experience converge. PLoS Pathog 2008; 4: e38.
    • (2008) PLoS Pathog , vol.4
    • Spellberg, B.1
  • 5
    • 77950215343 scopus 로고    scopus 로고
    • Candidosis, a new challenge
    • Lopez-Martinez R. Candidosis, a new challenge. Clin Dermatol 2010; 28: 178-84.
    • (2010) Clin Dermatol , vol.28 , pp. 178-184
    • Lopez-Martinez, R.1
  • 7
    • 0032862342 scopus 로고    scopus 로고
    • In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole
    • Carrillo-Munoz AJ, Quindos G, Tur C et al. In-vitro antifungal activity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulphate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluconazole and itraconazole. J Antimicrob Chemother 1999; 44: 397-401.
    • (1999) J Antimicrob Chemother , vol.44 , pp. 397-401
    • Carrillo-Munoz, A.J.1    Quindos, G.2    Tur, C.3
  • 8
    • 84857704675 scopus 로고    scopus 로고
    • Novel, unifying mechanism for amphotericin B and other polyene drugs: electron affinity, radicals, electron transfer, autoxidation, toxicity, and antifungal action
    • Kovacic P, Cooksy A. Novel, unifying mechanism for amphotericin B and other polyene drugs: electron affinity, radicals, electron transfer, autoxidation, toxicity, and antifungal action. Med Chem Commun 2012; 3: 274-80.
    • (2012) Med Chem Commun , vol.3 , pp. 274-280
    • Kovacic, P.1    Cooksy, A.2
  • 9
    • 84875503043 scopus 로고    scopus 로고
    • It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug
    • doi.103389/fmicb.2012.00286.
    • Mesa-Arango AC, Scorzoni L, Zaragoza O. It only takes one to do many jobs: amphotericin B as antifungal and immunomodulatory drug. Front Microbiol 2012; doi:10.3389/fmicb.2012.00286.
    • (2012) Front Microbiol
    • Mesa-Arango, A.C.1    Scorzoni, L.2    Zaragoza, O.3
  • 10
    • 84882612782 scopus 로고    scopus 로고
    • Ratiopharm. Product Monograph (ratio-Nystatin)
    • Ratiopharm. Product Monograph (ratio-Nystatin). 2001; G50-G5.
    • (2001)
  • 12
    • 0030927488 scopus 로고    scopus 로고
    • Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions
    • Pons V, Greenspan D, Lozada-Nur F et al. Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clin Infect Dis 1997; 24: 1204-7.
    • (1997) Clin Infect Dis , vol.24 , pp. 1204-1207
    • Pons, V.1    Greenspan, D.2    Lozada-Nur, F.3
  • 13
    • 36248953162 scopus 로고    scopus 로고
    • Drug-drug interactions with systemic antifungals in clinical practice
    • Depont F, Vargas F, Dutronc H et al. Drug-drug interactions with systemic antifungals in clinical practice. Pharmacoepidemiol Drug Saf 2007; 16: 1227-33.
    • (2007) Pharmacoepidemiol Drug Saf , vol.16 , pp. 1227-1233
    • Depont, F.1    Vargas, F.2    Dutronc, H.3
  • 14
    • 0026574215 scopus 로고
    • Safety and pharmacokinetics of fluconazole in children with neoplastic diseases
    • Lee JW, Seibel NL, Amantea M et al. Safety and pharmacokinetics of fluconazole in children with neoplastic diseases. J Pediatr 1992; 120: 987-93.
    • (1992) J Pediatr , vol.120 , pp. 987-993
    • Lee, J.W.1    Seibel, N.L.2    Amantea, M.3
  • 15
    • 76649114370 scopus 로고    scopus 로고
    • Antifungal drug resistance of oral fungi
    • Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology 2010; 98: 15-25.
    • (2010) Odontology , vol.98 , pp. 15-25
    • Niimi, M.1    Firth, N.A.2    Cannon, R.D.3
  • 16
    • 0036125293 scopus 로고    scopus 로고
    • Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis
    • Martinez M, Lopez-Ribot JL, Kirkpatrick WR et al. Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 2002; 49: 515-24.
    • (2002) J Antimicrob Chemother , vol.49 , pp. 515-524
    • Martinez, M.1    Lopez-Ribot, J.L.2    Kirkpatrick, W.R.3
  • 17
    • 0037453179 scopus 로고    scopus 로고
    • Formulation of amphotericin B as nanosuspension for oral administration
    • Kayser O, Olbrich C, Yardley V et al. Formulation of amphotericin B as nanosuspension for oral administration. Int J Pharm 2003; 254: 73-5.
    • (2003) Int J Pharm , vol.254 , pp. 73-75
    • Kayser, O.1    Olbrich, C.2    Yardley, V.3
  • 18
    • 77955274105 scopus 로고    scopus 로고
    • Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas
    • Lemke A, Kiderlen AF, Petri B et al. Delivery of amphotericin B nanosuspensions to the brain and determination of activity against Balamuthia mandrillaris amebas. Nanomedicine 2010; 6: 597-603.
    • (2010) Nanomedicine , vol.6 , pp. 597-603
    • Lemke, A.1    Kiderlen, A.F.2    Petri, B.3
  • 19
    • 80053613500 scopus 로고    scopus 로고
    • Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome(R) or Fungizone
    • Italia JL, Sharp A, Carter KC et al. Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome(R) or Fungizone. PLoS One 2011; 6: e25744.
    • (2011) PLoS One , vol.6
    • Italia, J.L.1    Sharp, A.2    Carter, K.C.3
  • 20
    • 80155182415 scopus 로고    scopus 로고
    • Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice
    • Xu N, Gu J, Zhu Y et al. Efficacy of intravenous amphotericin B-polybutylcyanoacrylate nanoparticles against cryptococcal meningitis in mice. Int J Nanomedicine 2011; 6: 905-13.
    • (2011) Int J Nanomedicine , vol.6 , pp. 905-913
    • Xu, N.1    Gu, J.2    Zhu, Y.3
  • 21
    • 84866010671 scopus 로고    scopus 로고
    • Antibacterial activity of silver bionanocomposites synthesized by chemical reduction route
    • Bin Ahmad M, Lim JJ, Shameli K et al. Antibacterial activity of silver bionanocomposites synthesized by chemical reduction route. Chem Cent J 2012; 6: 101.
    • (2012) Chem Cent J , vol.6 , pp. 101
    • Bin Ahmad, M.1    Lim, J.J.2    Shameli, K.3
  • 22
    • 80051616272 scopus 로고    scopus 로고
    • Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties
    • Dal Lago V, Franca de Oliveira L, de Almeida Goncalves K et al. Size-selective silver nanoparticles: future of biomedical devices with enhanced bactericidal properties. J Mater Chem 2011; 21: 12267-73.
    • (2011) J Mater Chem , vol.21 , pp. 12267-73
    • Dal Lago, V.1    Franca de Oliveira, L.2    de Almeida Goncalves, K.3
  • 24
    • 0029147517 scopus 로고
    • Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin
    • Flynn PM, Cunningham CK, Kerkering Tet al. Oropharyngeal candidiasis in immunocompromised children: a randomized, multicenter study of orally administered fluconazole suspension versus nystatin. The Multicenter Fluconazole Study Group. J Pediatr 1995; 127: 322-8.
    • (1995) The Multicenter Fluconazole Study Group. J Pediatr , vol.127 , pp. 322-328
    • Flynn, P.M.1    Cunningham, C.K.2    Kerkering, T.3
  • 25
    • 65949123789 scopus 로고    scopus 로고
    • Novel mucoadhesive extended release tablets for treatment of oral candidosis: 'in vivo' evaluation of the biopharmaceutical performance
    • Llabot JM, Manzo RH, Allemandi DA. Novel mucoadhesive extended release tablets for treatment of oral candidosis: 'in vivo' evaluation of the biopharmaceutical performance. J Pharm Sci 2009; 98: 1871-6.
    • (2009) J Pharm Sci , vol.98 , pp. 1871-1876
    • Llabot, J.M.1    Manzo, R.H.2    Allemandi, D.A.3
  • 27
    • 84865359224 scopus 로고    scopus 로고
    • Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: Ultrastructural effects and release studies
    • Campos FF, Calpena Campmany AC, Delgado GR et al. Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: Ultrastructural effects and release studies. J Pharm Sci 2012; 101: 3739-52.
    • (2012) J Pharm Sci , vol.101 , pp. 3739-3752
    • Campos, F.F.1    Calpena Campmany, A.C.2    Delgado, G.R.3
  • 28
    • 0033802638 scopus 로고    scopus 로고
    • In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect
    • Gunderson SM, Hoffman H, Ernst EJ et al. In vitro pharmacodynamic characteristics of nystatin including time-kill and postantifungal effect. Antimicrob Agents Chemother 2000; 44: 2887-90.
    • (2000) Antimicrob Agents Chemother , vol.44 , pp. 2887-2890
    • Gunderson, S.M.1    Hoffman, H.2    Ernst, E.J.3
  • 31
    • 0025315944 scopus 로고
    • Experimental oral candidosis in the mouse: microbiologic and histologic aspects
    • Lacasse M, Fortier C, Trudel L et al. Experimental oral candidosis in the mouse: microbiologic and histologic aspects. J Oral Pathol Med 1990; 19: 136-41.
    • (1990) J Oral Pathol Med , vol.19 , pp. 136-141
    • Lacasse, M.1    Fortier, C.2    Trudel, L.3
  • 32
    • 0033490423 scopus 로고    scopus 로고
    • High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies
    • Groll AH, Mickiene D, Werner K et al. High-performance liquid chromatographic determination of liposomal nystatin in plasma and tissues for pharmacokinetic and tissue distribution studies. J Chromatogr B Biomed Sci Appl 1999; 735: 51-62.
    • (1999) J Chromatogr B Biomed Sci Appl , vol.735 , pp. 51-62
    • Groll, A.H.1    Mickiene, D.2    Werner, K.3
  • 33
    • 84858129679 scopus 로고    scopus 로고
    • Mouse model of oropharyngeal candidiasis
    • Solis NV, Filler SG. Mouse model of oropharyngeal candidiasis. Nat Protoc 2012; 7: 637-42.
    • (2012) Nat Protoc , vol.7 , pp. 637-642
    • Solis, N.V.1    Filler, S.G.2
  • 34
    • 62549159532 scopus 로고    scopus 로고
    • Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1
    • de Repentigny L, Lewandowski D, Aumont F et al. Oral mucosal cell response to Candida albicans in transgenic mice expressing HIV-1. Methods Mol Biol 2009; 470: 359-68.
    • (2009) Methods Mol Biol , vol.470 , pp. 359-368
    • de Repentigny, L.1    Lewandowski, D.2    Aumont, F.3
  • 35
    • 41949100244 scopus 로고    scopus 로고
    • Drug nanoparticles: formulating poorly water-soluble compounds
    • Merisko-Liversidge EM, Liversidge GG. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol 2008; 36: 43-8.
    • (2008) Toxicol Pathol , vol.36 , pp. 43-48
    • Merisko-Liversidge, E.M.1    Liversidge, G.G.2
  • 38
  • 39
    • 84857799575 scopus 로고    scopus 로고
    • Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2)
    • Matsubara VH, Silva EG, Paula CR et al. Treatment with probiotics in experimental oral colonization by Candida albicans in murine model (DBA/2). Oral Dis 2012; 18: 260-4.
    • (2012) Oral Dis , vol.18 , pp. 260-264
    • Matsubara, V.H.1    Silva, E.G.2    Paula, C.R.3
  • 40
    • 0345269817 scopus 로고    scopus 로고
    • Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice
    • Ashman RB, Papadimitriou JM, Fulurija A et al. Role of complement C5 and T lymphocytes in pathogenesis of disseminated and mucosal candidiasis in susceptible DBA/2 mice. Microb Pathog 2003; 34: 103-13.
    • (2003) Microb Pathog , vol.34 , pp. 103-113
    • Ashman, R.B.1    Papadimitriou, J.M.2    Fulurija, A.3
  • 41
    • 0028406619 scopus 로고
    • Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice
    • Chakir J, Cote L, Coulombe C et al. Differential pattern of infection and immune response during experimental oral candidiasis in BALB/c and DBA/2 (H-2d) mice. Oral Microbiol Immunol 1994; 9: 88-94.
    • (1994) Oral Microbiol Immunol , vol.9 , pp. 88-94
    • Chakir, J.1    Cote, L.2    Coulombe, C.3
  • 42
    • 79955450697 scopus 로고    scopus 로고
    • Genetic control of susceptibility to infection with Candida albicans in mice
    • Radovanovic I, Mullick A, Gros P. Genetic control of susceptibility to infection with Candida albicans in mice. PLoS One 2011; 6: e18957.
    • (2011) PLoS One , vol.6
    • Radovanovic, I.1    Mullick, A.2    Gros, P.3
  • 43
    • 0037090333 scopus 로고    scopus 로고
    • Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1
    • de Repentigny L, Aumont F, Ripeau JS et al. Mucosal candidiasis in transgenic mice expressing human immunodeficiency virus type 1. J Infect Dis 2002; 185: 1103-14.
    • (2002) J Infect Dis , vol.185 , pp. 1103-1114
    • de Repentigny, L.1    Aumont, F.2    Ripeau, J.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.